Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer.
Beg, Muhammad Shaalan⋅Huang, Xiumei⋅Silvers, Molly A⋅Gerber, David E⋅Bolluyt, Joyce⋅Sarode, Venetia⋅Fattah, Farjana⋅Deberardinis, Ralph J⋅Merritt, Matthew E⋅Xie, Xian-Jin⋅Leff, Richard⋅Laheru, Daniel and Boothman, David A
Journal of surgical oncology, vol. 116, (no. 1), pp. 83-88, July 2017. | Journal Article